Showing 1 - 10 of 36
Does using prescription drugs off-label increase disability and medical expenditure? This paper uses a unique dataset to evaluate off-label vs. on-label drug use in the US non-institutionalized population. Patients using drugs off-label have on average $515 higher medical expenditure and...
Persistent link: https://www.econbiz.de/10013412986
Cost‐control interventions that target physicians' clinical discretion are common in healthcare, but evidence on their efficacy is scarce; in particular for "soft" policies when liability is unlikely to be enforced by the regulator. We study the effectiveness of preferred drug policies (minimum...
Persistent link: https://www.econbiz.de/10014000571
In dynamic markets, organizations have to be ambidextrous to adapt to constant change. Simultaneously, organizations are increasingly required to adopt quality management accreditation. Standardization through accreditation bares the risk of limiting an organization's dynamic capabilities. In...
Persistent link: https://www.econbiz.de/10014495332
We investigated the role of public funding in cardiovascular device innovation across 31 countries in Europe. We rely on the knowledge production function (KPF) framework that establishes the knowledge output of a region as a function of innovatory effort and other characteristics of that...
Persistent link: https://www.econbiz.de/10015324910
Persistent link: https://www.econbiz.de/10014521595
In the expected-utility theory of the monetary value of a statistical life, the so-called "dead-anyway" effect discovered by Pratt and Zeckhauser (1996) asserts that an individuals' willingness to pay (WTP) for small reductions in mortality risk increases with the initial level of risk. Their...
Persistent link: https://www.econbiz.de/10010315735
This experiment investigates decisions made by prospective economists and physicians in an allocation problem which can be framed either medically or neutrally. The potential recipients differ with respect to their minimum needs as well as to how much they benefit from a treatment. We classify...
Persistent link: https://www.econbiz.de/10010317169
Die Diskussion um die Reform des deutschen Krankenversicherungsmarktes kreist seit mehreren Jahren um die beiden Reformoptionen 'Gesundheitsprämie' und 'Bürgerversicherung'. Seit der Veröffentlichung des Berichts der sogenannten 'Rürup-Kommission' im Jahr 2003 wird die 'Bürgerversicherung'...
Persistent link: https://www.econbiz.de/10010320013
Persistent link: https://www.econbiz.de/10014523252
Persistent link: https://www.econbiz.de/10014524211